European life sciences investor Medicxi has hit a €200m final close for its debut secondaries fund amid using the vehicle to pick up six companies from one of the firm’s previous funds.
biotech
clinical
Europe
Fund
fund close
fundraise
Fundraising
Funds Closed
Index venture
life science
medical
Medicxi
private equity
Secondaries
Software and Hi-Tech
Valuation and Exit
Venture/Growth
Western Europe
Medicxi pioneers ‘exit and reinvest’ for biotech sector with €200m close of debut secondaries fund
Most Popular
